Why ZEUS? Interleukin-6 as the next potential frontier in anti-inflammatory management of atherosclerotic cardiovascular disease
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Risk Factors and Prevention
Session type:
Satellite Symposium
Sponsored by Novo Nordisk A/S
Date:
29 August 2021
Time:
11:30
-
12:00
Session
This content is currently on OPEN ACCESS
2 presentations in this session
2 speakers from this session
Professor Peter
Libby
Brigham and Women's Hospital, Boston (United States of America)
28
presentations
2
followers
Doctor Paul M
Ridker
Brigham and Women's Hospital, Boston (United States of America)
25
presentations
2
followers
This platform is supported by
